69 related articles for article (PubMed ID: 21964586)
21. Genetic polymorphisms in the P2X7 gene and its association with susceptibility to tuberculosis.
Singla N; Gupta D; Joshi A; Batra N; Singh J
Int J Tuberc Lung Dis; 2012 Feb; 16(2):224-9. PubMed ID: 22137490
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-10 (IL-10) gene polymorphism as a potential host susceptibility factor in tuberculosis.
Oral HB; Budak F; Uzaslan EK; Baştürk B; Bekar A; Akalin H; Ege E; Ener B; Göral G
Cytokine; 2006 Aug; 35(3-4):143-7. PubMed ID: 16962335
[TBL] [Abstract][Full Text] [Related]
23. [Preliminary study on the association of chemokine RANTES gene polymorphisms with HIV-1 infection in Chinese Han population].
Liu XL; Wang FS; Jin L; Liu MX; Xu DZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):971-5. PubMed ID: 14687494
[TBL] [Abstract][Full Text] [Related]
24. [The current and future situations of TB/HIV (co-infection of tuberculosis and HIV) in Japan].
Yamada N; Nagai H
Kekkaku; 2009 Apr; 84(4):203-11. PubMed ID: 19425395
[TBL] [Abstract][Full Text] [Related]
25. Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease.
Karasneh J; Hajeer AH; Barrett J; Ollier WE; Thornhill M; Gul A
Rheumatology (Oxford); 2003 Jul; 42(7):860-4. PubMed ID: 12730545
[TBL] [Abstract][Full Text] [Related]
26. IFNG +874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis.
Vallinoto AC; Graça ES; Araújo MS; Azevedo VN; Cayres-Vallinoto I; Machado LF; Ishak MO; Ishak R
Hum Immunol; 2010 Jul; 71(7):692-6. PubMed ID: 20353805
[TBL] [Abstract][Full Text] [Related]
27. No association between the +874T/A single nucleotide polymorphism in the IFN-gamma gene and susceptibility to TB.
Moran A; Ma X; Reich RA; Graviss EA
Int J Tuberc Lung Dis; 2007 Jan; 11(1):113-5. PubMed ID: 17217140
[TBL] [Abstract][Full Text] [Related]
28. Association of PTPN22 gene functional variants with development of pulmonary tuberculosis in Moroccan population.
Lamsyah H; Rueda B; Baassi L; Elaouad R; Bottini N; Sadki K; Martin J
Tissue Antigens; 2009 Sep; 74(3):228-32. PubMed ID: 19563523
[TBL] [Abstract][Full Text] [Related]
29. Genetic association in
Bellah SF; Salam MA; Billah SMS; Karim MR
Ann Hum Biol; 2023 Feb; 50(1):63-74. PubMed ID: 36688864
[TBL] [Abstract][Full Text] [Related]
30. Genetic analysis of drug metabolizing phase-I enzymes CYP3A4 in Tibetan populations.
Liu L; Chang Y; Du S; Shi X; Yang H; Kang L; Jin T; Yuan D; He Y
J Genet; 2017 Jun; 96(2):219-225. PubMed ID: 28674221
[TBL] [Abstract][Full Text] [Related]
31. Increased transcriptional activity of the CYP3A4*1B promoter variant.
Amirimani B; Ning B; Deitz AC; Weber BL; Kadlubar FF; Rebbeck TR
Environ Mol Mutagen; 2003; 42(4):299-305. PubMed ID: 14673875
[TBL] [Abstract][Full Text] [Related]
32. The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer.
Spurdle AB; Goodwin B; Hodgson E; Hopper JL; Chen X; Purdie DM; McCredie MR; Giles GG; Chenevix-Trench G; Liddle C
Pharmacogenetics; 2002 Jul; 12(5):355-66. PubMed ID: 12142725
[TBL] [Abstract][Full Text] [Related]
33. Estimation of CYP3A4*1B single nucleotide polymorphism in patients with recurrent Major Depressive Disorder.
Świechowski R; Jeleń A; Mirowski M; Talarowska M; Gałecki P; Pietrzak J; Wodziński D; Balcerczak E
Mol Genet Genomic Med; 2019 Jun; 7(6):e669. PubMed ID: 31025537
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility to Mycobacterium tuberculosis infection in HIV-positive patients is associated with CARD8 genetic variant.
Pontillo A; Carvalho MS; Kamada AJ; Moura R; Schindler HC; Duarte AJ; Crovella S
J Acquir Immune Defic Syndr; 2013 Jun; 63(2):147-51. PubMed ID: 23507658
[TBL] [Abstract][Full Text] [Related]
35. Contrasting exome constancy and regulatory region variation in the gene encoding CYP3A4: an examination of the extent and potential implications.
Creemer OJ; Ansari-Pour N; Ekong R; Tarekegn A; Plaster C; Bains RK; Itan Y; Bekele E; Bradman N
Pharmacogenet Genomics; 2016 Jun; 26(6):255-70. PubMed ID: 27139836
[TBL] [Abstract][Full Text] [Related]
36. Association of the CYP2B6 gene with anti-tuberculosis drug-induced hepatotoxicity in a Brazilian Amazon population.
Fernandes DC; Santos NP; Moraes MR; Braga AC; Silva CA; Ribeiro-dos-Santos A; Santos S
Int J Infect Dis; 2015 Apr; 33():28-31. PubMed ID: 25271170
[TBL] [Abstract][Full Text] [Related]
37. Relationship of
Parkhomenko AA; Zastrozhin MS; Skryabin V; Petukhov AE; Pozdniakov SA; Ivanchenko VA; Zaytsev IA; Bure IV; Bochkov PO; Akmalova KA; Smirnov VV; Bryun EA; Sychev DA
Psychopharmacol Bull; 2023 Dec; 53(4):8-14. PubMed ID: 38076668
[TBL] [Abstract][Full Text] [Related]
38. Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.
Rebbeck TR; Jaffe JM; Walker AH; Wein AJ; Malkowicz SB
J Natl Cancer Inst; 1998 Aug; 90(16):1225-9. PubMed ID: 9719084
[TBL] [Abstract][Full Text] [Related]
39. CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy.
Elens L; van Gelder T; Hesselink DA; Haufroid V; van Schaik RH
Pharmacogenomics; 2013 Jan; 14(1):47-62. PubMed ID: 23252948
[TBL] [Abstract][Full Text] [Related]
40. CYP3A4*1B polymorphism and cancer risk: a HuGE review and meta-analysis.
Zhou LP; Yao F; Luan H; Wang YL; Dong XH; Zhou WW; Wang QH
Tumour Biol; 2013 Apr; 34(2):649-60. PubMed ID: 23179402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
